Alector (ALEC) Revenue & Revenue Breakdown
Alector Revenue Highlights
Latest Revenue (Y)
$97.06M
Latest Revenue (Q)
$15.89M
Main Segment (Y)
Phase Three License
Main Geography (Y)
Phase Three License
Alector Revenue by Period
Alector Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | $97.06M | -27.36% |
2022-12-31 | $133.62M | -35.48% |
2021-12-31 | $207.09M | 881.54% |
2020-12-31 | $21.10M | -0.57% |
2019-12-31 | $21.22M | -23.33% |
2018-12-31 | $27.68M | 641.02% |
2017-12-31 | $3.73M | 797.84% |
2016-12-31 | $416.00K | - |
Alector Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-03-31 | $15.89M | 4.63% |
2023-12-31 | $15.19M | 66.76% |
2023-09-30 | $9.11M | -83.80% |
2023-06-30 | $56.21M | 239.68% |
2023-03-31 | $16.55M | 14.61% |
2022-12-31 | $14.44M | -2.77% |
2022-09-30 | $14.85M | -81.40% |
2022-06-30 | $79.85M | 226.27% |
2022-03-31 | $24.47M | 74.89% |
2021-12-31 | $13.99M | -92.33% |
2021-09-30 | $182.41M | 2677.30% |
2021-06-30 | $6.57M | 59.81% |
2021-03-31 | $4.11M | -15.31% |
2020-12-31 | $4.85M | -17.80% |
2020-09-30 | $5.90M | 86.25% |
2020-06-30 | $3.17M | -55.79% |
2020-03-31 | $7.17M | 19.50% |
2019-12-31 | $6.00M | 122.59% |
2019-09-30 | $2.70M | -61.02% |
2019-06-30 | $6.92M | 23.41% |
2019-03-31 | $5.61M | -38.71% |
2018-12-31 | $9.14M | 40.63% |
2018-09-30 | $6.50M | -8.52% |
2018-06-30 | $7.11M | 44.49% |
2018-03-31 | $4.92M | 60.84% |
2017-12-31 | $3.06M | 1899.35% |
2017-09-30 | $153.00K | -41.49% |
2017-06-30 | $261.50K | - |
2017-03-31 | $261.50K | - |
Alector Revenue Breakdown
Alector Revenue Breakdown by Product
Annual Revenue by Product
Product/Service | Dec 21 |
---|---|
Phase Three License | $173.40M |
Quarterly Revenue by Product
Product/Service | Sep 21 |
---|---|
Phase Three License | $173.40M |
Alector Revenue Breakdown by Country
Annual Revenue by Country
Country | Dec 21 |
---|---|
Phase Three License | $173.40M |
Quarterly Revenue by Country
Country | Sep 21 |
---|---|
Phase Three License | $173.40M |
Alector Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
ALEC | Alector | $97.06M | $15.89M |
RVMD | Revolution Medicines, Inc. Warrant | $11.58M | - |
STOK | Stoke Therapeutics | $8.78M | $4.22M |
FIXX | Q32 Bio | $1.16M | - |
BCEL | Atreca | $770.00K | $80.00K |
BDTX | Black Diamond Therapeutics | - | - |
CABA | Cabaletta Bio | - | - |
PASG | Passage Bio | - | - |
LRMR | Larimar Therapeutics | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
ALEC Revenue FAQ
What is Alector’s yearly revenue?
Alector's yearly revenue for 2023 was $97.06M, representing a decrease of -27.36% compared to 2022. The company's yearly revenue for 2022 was $133.62M, representing a decrease of -35.48% compared to 2021. ALEC's yearly revenue for 2021 was $207.08M, representing an increase of 881.54% compared to 2020.
What is Alector’s quarterly revenue?
Alector's quarterly revenue for Q1 2024 was $15.89M, a 4.63% increase from the previous quarter (Q4 2023), and a -3.96% decrease year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $15.19M, a 66.76% increase from the previous quarter (Q3 2023), and a 5.19% increase year-over-year (Q4 2022). ALEC's quarterly revenue for Q3 2023 was $9.11M, a -83.80% decrease from the previous quarter (Q2 2023), and a -38.67% decrease year-over-year (Q3 2022).
What is Alector’s revenue growth rate?
Alector's revenue growth rate for the last 3 years (2021-2023) was -53.13%, and for the last 5 years (2019-2023) was 357.43%.
What are Alector’s revenue streams?
Alector's revenue streams in c 21 are Phase Three License
What is Alector’s main source of revenue?
For the fiscal year ending Dec 21, the largest source of revenue of Alector was Phase Three License. This segment made a revenue of $173.4M, representing 100.00% of the company's total revenue.